Net income
-110 million USD
2025-10-01 – 2026-09-30
Market value
$155.16M
45,235,568 shares as of 2026-10-30, at $3.43 a share (SION, IEX close on 2026-11-12) Primary-source evidence
11 filing records in this dataset, filed from 2025-01-17 to 2026-11-10. Reported financial figures are available; chart coverage varies by period.
Transactions reported by directors, officers and 10% owners on SEC Forms 3, 4 and 5, over the last 12 months.
Window: transactions dated on or after 2025-11-17.
Totals add the filed transactions listed; they are counts of what was reported, not a measure of direction.
83878000 USD
45214369 shares
1.69% · 751 thousand shares
Year-over-year change in reported shares. Splits, issuance and buybacks can affect this figure; it does not isolate employee compensation or economic dilution.
The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.
-110 million USD
2025-10-01 – 2026-09-30
-79.4 million USD
2025-10-01 – 2026-09-30
204 thousand USD
2025-10-01 – 2026-09-30
-79.6 million USD
2025-10-01 – 2026-09-30
Includes later revisions to earlier periods. Annual charts exclude incomplete years.
Latest filing recorded: 2026-11-10.
Financial data available through: 2025-12-31.
Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.
Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.
Prior period
−USD 61.69 million
–
Current period
−USD 75.27 million
–
-75268000 − -61688000 = -13580000 USD
-61688000 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source-75268000 USD · 2025-01-01 – 2025-12-31
Inspect current input Current sourceThe citation records this snapshot. The page link may show a newer release later.
Prior period
−USD 52.79 million
–
Current period
−USD 66.3 million
–
-66297000 − -52787000 = -13510000 USD
-52787000 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source-66297000 USD · 2025-01-01 – 2025-12-31
Inspect current input Current sourceThe citation records this snapshot. The page link may show a newer release later.
Prior period
USD 27,000
–
Current period
USD 377,000
–
377000 − 27000 = 350000 USD
27000 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source377000 USD · 2025-01-01 – 2025-12-31
Inspect current input Current sourceThe citation records this snapshot. The page link may show a newer release later.
Comparable inputs unavailable for: Revenue.
How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.
Revenue is not reported for this company, so its costs cannot be shown as a share of it.
Sales over time and how quickly they are changing.
Revenue reported for each complete financial period.
| Period | Series | Value | Source evidence |
|---|
Change in revenue from the same financial period one year earlier.
| Period | Series | Value | Source evidence |
|---|
How much revenue becomes profit, and how much cash operations generate.
Operating income, net income and free cash flow as a share of revenue.
| Period | Series | Value | Source evidence |
|---|
Cash generated by the company’s normal business operations.
| Period | Series | Value | Source evidence |
|---|
Operating cash flow minus capital expenditure for the same period and unit.
| Period | Series | Value(USD) | Source evidence |
|---|
Liabilities and short-term ability to meet obligations at each period end.
Total liabilities as a share of total assets.
| Period | Series | Value | Source evidence |
|---|
Current assets divided by current liabilities.
| Period | Series | Value | Source evidence |
|---|
Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.
| Period | Net income | Operating cash flow | Capital expenditure | Free cash flow |
|---|---|---|---|---|
| 2024 2024-01-01 – 2024-12-31 | −USD 61.69 million Exact valueExact value: -61688000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 52.79 million Exact valueExact value: -52787000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 27,000 Exact valueExact value: 27000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 52.81 million Calculation and evidence-52787000 − 27000 USD Exact free cash flow: -52814000 USD
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
| 2025 2025-01-01 – 2025-12-31 | −USD 75.27 million Exact valueExact value: -75268000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 66.3 million Exact valueExact value: -66297000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 377,000 Exact valueExact value: 377000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 66.67 million Calculation and evidence-66297000 − 377000 USD Exact free cash flow: -66674000 USD
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.
Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.
11 filings · 556 latest values · 556 originally reported values
Dataset published . Source filing dates and reporting periods are shown separately.
Identifiers: 0002036042, 2036042, SION, edgar:2036042
Also known as SIONNA THERAPEUTICS, INC., Sionna Therapeutics, Inc.